A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Apollo Therapeutics Ltd
- Study ID
- NCT07599813
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Atopic
- Atopic Dermatitis
- Dermatitis
- Dermatitis, Atopic
- Dermatologic Disease
- Eczema
- Eczema Atopic Dermatitis
- Eczema, Atopic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Camoteskimab — DRUGDrug Product
- Placebo — DRUGInactive substance
Study Details
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Key Dates
- Start date
- May 28, 2026
- Status verified
- May 2026
- Primary completion
- Oct 31, 2027
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 280 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dose 1Camoteskimab administered subcutaneously
- Experimental: Dose 2Camoteskimab administered subcutaneously
- Experimental: Dose 3Camoteskimab administered subcutaneously
- Placebo Comparator: PlaceboDummy version of the study drug administered subcutaneously
Primary Outcome Measure
Percentage change from baseline in Eczema Area and Severity Index (EASI) between camoteskimab and placebo at Week 24 [ Time Frame: From Baseline visit until Week 24 visit ]
Locations (33)
Find similar trials in Birmingham, AL
By condition
By specialty
Related Studies
- Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Studies of Skin Microbes in Healthy People and in People With Skin ConditionsRecruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Effects of Treatments on Atopic DermatitisPHASE2 · Recruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- Natural History and Genetics of Food Allergy and Related ConditionsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland